CervoMed Inc. (CRVO)
NASDAQ: CRVO · IEX Real-Time Price · USD
15.97
-0.29 (-1.75%)
Jul 22, 2024, 11:35 AM EDT - Market open
CervoMed Employees
CervoMed had 8 employees as of December 31, 2023. The number of employees increased by 4 or 100.00% compared to the previous year.
Employees
8
Change (1Y)
4
Growth (1Y)
100.00%
Revenue / Employee
$795,539
Profits / Employee
-$604,934
Market Cap
139.69M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 8 | 4 | 100.00% |
| Dec 31, 2022 | 4 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Harvard Bioscience | 416 |
| Amylyx Pharmaceuticals | 384 |
| Veru Inc. | 189 |
| Electromed | 170 |
| Inventiva | 123 |
| Invivyd | 95 |
| Compass Therapeutics | 32 |
| Corvus Pharmaceuticals | 28 |
CRVO News
- 5 days ago - CervoMed to Participate in the Emerging Growth Conference - GlobeNewsWire
- 11 days ago - CervoMed to Host Virtual KOL Event on Neflamapimod for Dementia with Lewy Bodies on July 23, 2024 - GlobeNewsWire
- 5 weeks ago - CervoMed Announces Completion of Enrollment in Phase 2b RewinD-LB Clinical Trial of Neflamapimod for the Treatment of Patients with Dementia with Lewy Bodies - GlobeNewsWire
- 2 months ago - CervoMed to Appoint William Elder as Chief Financial Officer - GlobeNewsWire
- 2 months ago - CervoMed Reports First Quarter 2024 Financial Results and Provides Corporate Updates - GlobeNewsWire
- 4 months ago - CervoMed Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Updates - GlobeNewsWire
- 4 months ago - CervoMed to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 4 months ago - CervoMed Announces Up to $149.4 Million Private Placement Financing Joined by Leading Healthcare Investors - GlobeNewsWire